COVID-19-associated Pulmonary Aspergillosis: A Case Series.
Indian J Crit Care Med
; 26(9): 1039-1041, 2022 Sep.
Article
in English
| MEDLINE | ID: covidwho-2266310
ABSTRACT
Background:
With the development of coronavirus disease-2019 (COVID-19) pandemic, there is also increased risk of multiple secondary infections either disease- or drug-related. It includes many bacterial as well as invasive fungal infections. Patients andmethods:
There was suspicion of invasive pulmonary aspergillosis (IPA) infection in COVID-19 patients who were critically ill and had acute respiratory distress syndrome (ARDS). We did radiological evaluation and galactomannan assay in these patients.Result:
We have diagnosed COVID-19-associated pulmonary aspergillosis (CAPA) in these patients and started antifungal treatment with voriconazole in all of these COVID-19 patients.Conclusion:
It is very important to report such cases, so that healthcare professionals and authorities related to healthcare will be aware of and may also prepare for the increasing burden of this complication. We describe a case series of CAPA infection. How to cite this article Sharma K, Kujur R, Sharma S, Kumar N, Ray MK. COVID-19-associated Pulmonary Aspergillosis A Case Series. Indian J Crit Care Med 2022;26(9)1039-1041.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Experimental Studies
/
Prognostic study
Language:
English
Journal:
Indian J Crit Care Med
Year:
2022
Document Type:
Article
Affiliation country:
Jp-journals-10071-24314
Similar
MEDLINE
...
LILACS
LIS